CELULARITY

Celularity is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified NK cells, genetically-modified NK cells, T cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer, infectious and degenerative diseases. Celularity believes that by harnessing the placenta’s unique biology and ready availability, it will be able to develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies.

#SimilarOrganizations #People #Financial #Website #More

CELULARITY

Social Links:

Facebook

Twitter

Instagram

Youtube

Industry:

Biotechnology Health Care Therapeutics Wellness

Founded:

2017-09-01

Address:

Florham Park, New Jersey, United States

Country:

United States

Website Url:

http://www.celularity.com

Total Employee:

101+

Status:

Active

Contact:

908-768-2170

Email Addresses:

[email protected]

Total Funding:

400 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics

Similar Organizations

alx-oncology-logo

ALX Oncology

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

arcellx-logo

Arcellx

Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.

gritstone-bio-logo

Gritstone Bio

Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.

passage-bio-logo

Passage Bio

Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.

scout-bio-logo

Scout Bio

Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.

x4-pharmaceuticals-logo

X4 Pharmaceuticals

X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.

Current Advisors List

robert-j-hariri_image

Robert J. Hariri Founder & Chairman @ Celularity
Board_member

peter-diamandis_image

Peter Diamandis Co-founder & Vice Chiarman @ Celularity
Board_member

not_available_image

Jay Bloom Board Member @ Celularity
Board_member

robin-l-smith_image

Robin L. Smith Board Member @ Celularity
Board_member

dean-kehler_image

Dean Kehler Board Member @ Celularity
Board_member

andrew-von-eschenbach_image

Andrew von Eschenbach Board Member @ Celularity
Board_member

tan-thay_image

Tan Thay Board Member @ Celularity
Board_member

marc-mazur_image

Marc Mazur Board Member @ Celularity
Board_member

Current Employees Featured

robert-j-hariri_image

Robert J. Hariri
Robert J. Hariri Founder, Chairperson, and Chief Executive Officer @ Celularity
Founder, Chairperson, and Chief Executive Officer
2016-10-01

john-r-haines_image

John R Haines
John R Haines Executive Vice President and Chief Operations & Administrative Officer @ Celularity
Executive Vice President and Chief Operations & Administrative Officer
2017-02-01

not_available_image

David C. Beers
David C. Beers Chief Financial Officer @ Celularity
Chief Financial Officer
2020-01-01

bradley-glover_image

Bradley Glover
Bradley Glover Executive Vice President and Chief Technology Officer @ Celularity
Executive Vice President and Chief Technology Officer

sharmila-koppisetti_image

Sharmila Koppisetti
Sharmila Koppisetti Vice President, Drug Safety/Pharmacovigilance @ Celularity
Vice President, Drug Safety/Pharmacovigilance

ankur-k-garg_image

Ankur K Garg
Ankur K Garg Executive Director, Brand & Content Strategy @ Celularity
Executive Director, Brand & Content Strategy
2020-04-01

not_available_image

Stephen A. Brigido, Chairman, SAB
Stephen A. Brigido, Chairman, SAB President- Functional Regeneration @ Celularity
President- Functional Regeneration

adam-keuhn_image

Adam Keuhn
Adam Keuhn Senior Medical Director @ Celularity
Senior Medical Director

anne-jones_image

Anne Jones
Anne Jones Executive Vice President and Chief Business Officer @ Celularity
Executive Vice President and Chief Business Officer

not_available_image

Beth Steinbrenner
Beth Steinbrenner Executive Vice President Human Resources @ Celularity
Executive Vice President Human Resources

Founder

peter-diamandis_image

Peter Diamandis

robert-j-hariri_image

Robert J. Hariri

Stock Details

Company's stock symbol is NASDAQ:CELU

Acquisitions List

Date	Company	Article	Price
2018-08-31	Caricord	Caricord acquired by Celularity	N/A

Investors List

sorrento-therapeutics_image

Official Site Inspections

http://www.celularity.com Semrush global rank: 2.26 M Semrush visits lastest month: 8.43 K

Host Informations
Whois Informations

Loading ...